Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by scaleyon Apr 13, 2018 11:28pm
168 Views
Post# 27884063

RE:RE:RE:RE:RE:RE:RE:Target of .20 this week/early next week

RE:RE:RE:RE:RE:RE:RE:Target of .20 this week/early next week Okay, so. I totally believe if you didn’t get in at these prices, your missing out. Load up Monday if you can. Everything stops sliding somewhere. I can’t see getting it any cheaper than this. If it does get cheaper, buy more. We will  all remember when it was.21 , and most will regret not purchasing it. The stumble is over ( I honestly believe this). Doctors have been paid in cheap shares , of course everyone involved seeks success and nothing else. I personally believe that shareholders will see a share price of at least $2.10 near December 25th. There is just so much going on, it’s like it’s going to be one amazing news release after the other. If they nail this, $2.10 is my very low conservative number. What could it be in December? Who knows. 4? These people know what they are doing. This company will succeed. To many wizards. If you have got in a bit early, either average down or be patient, it’s low, you can’t lose at this price. My gut feeling is you snooze you lose . Get in soon . When it takes off, it’s not checking back. And when it snaps, it will be one wild ride. This stock is so cheap, it’s bizarre. My honest take on it. Good luck everyone. I wish you nothing but success, I congratulate you on owning this stock. It’s a smart play. 
Bullboard Posts